naringenin has been researched along with pyrazolanthrone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atsumi, T; Ishida, A; Kurokawa, M; Narumi, K; Sugita, C; Watanabe, H; Watanabe, W; Yoshida, H | 1 |
Li, X; Liu, F; Luo, J; Yang, H; Yang, Y; Zhao, Q | 1 |
2 other study(ies) available for naringenin and pyrazolanthrone
Article | Year |
---|---|
Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Anthracenes; Cell Line; Chemokine CCL2; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavanones; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Obesity; RNA, Messenger; Time Factors | 2014 |
Naringenin Exerts Cardiovascular Protective Effect in a Palmitate-Induced Human Umbilical Vein Endothelial Cell Injury Model via Autophagy Flux Improvement.
Topics: Acetylcysteine; Anthracenes; Apoptosis; Autophagy; Cardiotonic Agents; Chloroquine; Endothelium, Vascular; Flavanones; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; MAP Kinase Signaling System; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Palmitates; Pyridines; Reactive Oxygen Species | 2019 |